Konekte ak nou

EU

#EAPM - #Dyabèt 'gaye tankou dife sovaj' atravè glòb la: Join nou nan Milan pou kongrè nou an

SHARE:

pibliye

on

Nou itilize enskripsyon ou pou bay kontni nan fason ou te konsanti ak amelyore konpreyansyon nou sou ou. Ou ka koupe abònman nan nenpòt ki lè.

According to the World Health Organization (WHO), there are some 60 million people with diabetes in Europe, which equates to around 10.3% of men and 9.6% of women aged 25 years and above, ekri Ewopeyen Alliance pou Medsin pèsonalize (EAPM) Direktè Egzekitif Denis Horgan.    

In every age group, however, diabetes is on the up. And this rise is due mainly to people being overweight and obese, eating unhealthy diets and having a lack of physical activity.     WHO projects that, worldwide, diabetes deaths will have doubled from 2005 levels by 2030. Yes, double.

We live in an ageing population and the older a person is, the greater their risk of diabetes. But the really bad news is that type 2 diabetes (T2D) is increasing in all age groups, including children and adolescents.

Half of people with diabetes die of cardiovascular disease (primarily heart disease and stroke), and 10-20% of people with diabetes die of kidney failure.

Blindness is also an issue, as are nerve damage and kidney disease. More seriously, the overall risk of dying among people with diabetes is at least double the risk of those without it. Double again.

Against this backdrop, on 27 November, the Brussels-based European Alliance for Personalised Medicine (EAPM) will host a ‘track’ on diabetes as part of its second annual Congress, to be held this year in Milan (26-28 November).

Please see link to the congress programme.

reklam

Topics of the track sessions will include:

Type 1 diabetes (T1D) prevention and personalisation strategies in Europe
T1D complications – blindness and kidney disease in Europe
New technologies and personalisation in the area of diabetes
Value-based health care and personalisation

Prior to the EAPM event, this year’s World Diabetes Day will take place on 14 November, with the theme ‘The Family and Diabetes’. That theme will also be the focus of next year’s day, with the International Diabetes Foundation (IDF) aiming to raise awareness of the impact that diabetes has on the family, while promoting the role of the family in the management, care, prevention and education of diabetes.

IDF says that diabetes concerns every family, and they have a key role to play in addressing the modifiable risk factors for T2D. Therefore, families must be provided with the education, resources and environments to live a healthy lifestyle.

The federation says that early diagnosis and treatment are key to preventing complications and achieving healthy outcomes. Awareness of the signs, symptoms and risk factors for all types of diabetes are vital to help detect it early, although less than 25% of family members have access to relevant education programmes.      The IDF also points out that family support has been shown to have a substantial effect in improving health outcomes for people with diabetes.

Clearly, there are many issues surrounding this disease, and you can register for the dedicated track in Milan here.

As mentioned above, diabetes is a worldwide problem - often referred to as an an epidemic - and the US, a well as Europe, is certainly far from immune.

Desmond Schatz, of the American Diabetes Association, has said that diabetes “is spiralling out of control across the US and around the world”. However, there is little sense of urgency to raise it to a high-profile issue.

It should be as hot a topic as cancer, but it is not. Meanwhile, the lack of visibility also extends to the patient-doctor relationship.      Schatz asks how many patients with T2D “choose to be invisible largely because of their own sense of failure and the frustration they confront during an office visit, knowing their blood glucose is still poorly controlled, their weight has not changed, and little or no effort was made to diet or exercise”.

Meanwhile it is a fact that, at least in the US, most patients stop taking their prescribed medication(s) after between 6–12 months. This means they quickly lose most of the clinical benefit. Adherence is critical, but the figures are damning.

On top of this, deaths from missed diagnoses of T1D are still happening. And with T2D, consistent and timely diagnosis remains suboptimal, with evidence showing an average period of more than six years from onset to diagnosis.

Six years! That’s incredible.

The whole diabetes scenario isn’t helped by the fact that the public puts diabetes behind cancer and heart disease when ranked in importance and seriousness, and most citizens put the blame for the disease firmly on the sufferer’s lifestyle choices.

The end result of all the above is that diabetes has been compared to a wildfire raging through the globe, but yet the disease and health-care costs are not being dealt with by the world’s nations, including those in Europe.

So what can Europe do about it? Perhaps the EU’s Digital Health Agenda  can help…

Earlier this month a high-level round table discussion on’Enabling the Digital Transformation of Health and Care the Digital Single Market’ took place, in order to exchange views on the vision for the future.

While it didn’t focus particularly on diabetes, the round table looked at the potential for health of key technologies, such as artificial intelligence and high-performance computing, in helping to design new healthcare products, provide faster diagnosis and better treatments.

Digital technologies offer the opportunity to revolutionize the entire healthcare sector, and put patients at its centre. They can increase the well-being of citizens and radically change the way health and care services are delivered.

Such changes can benefit not only patients but also the sustainability of health-care systems across Europe. Current barriers, however, include market fragmentation and a lack of interoperability across health systems, while the uptake of digital solutions for health remains slow and varies greatly across member states and even the regions within them.

The necessary transformation cannot happen unless different stakeholders co-operate in a single effort. The health technology community is integral to success as its innovation will help shape the sector’s future. Encouraging investment is also key.

For its part, the European Commission has said that it will continue to work with all stakeholders on diverse issues, “ranging from interoperability and standards, privacy and security to IT infrastructure, supercomputing and artificial Intelligence”. This, it says, is in order to improve health outcomes for citizens, improve the long-term sustainability of health systems and stimulate growth.

As mentioned, the digital health agenda is not specifically about diabetes but, given the scale of the epidemic and the numbers going undiagnosed, plus faltering adherence that may be aided by technologies, any progress has to be welcomed.

Again, do come and join us for discussion in Milan, with a view to formulating concrete actions.

Pou enskri, tanpri klike isit la.  

To see the programme, tanpri klike isit la.

Pataje atik sa a:

EU Reporter pibliye atik ki soti nan yon varyete sous deyò ki eksprime yon pakèt pwen de vi. Pozisyon yo pran nan atik sa yo pa nesesèman sa yo nan EU Reporter.

Tendans